Neuroprotection in Multiple Sclerosis: A Therapeutic Approach

被引：0
作者：
Amir-Hadi Maghzi
Alireza Minagar
Emmanuelle Waubant
机构：
[1] University of California San Francisco (UCSF),Multiple Sclerosis Center, Department of Neurology
[2] Louisiana State University Health Sciences Center,Department of Neurology
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Pioglitazone; Retinal Nerve Fiber Layer; Retinal Nerve Fiber Layer Thickness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that is pathologically characterized by inflammatory demyelination and neurodegeneration. Axonal damage, along with neuronal loss, occurs from disease onset and may lead to progressive and permanent disability. In contrast with the inflammatory pathways, the molecular mechanisms leading to MS neurodegeneration remain largely elusive. With improved understanding of these mechanisms, new potential therapeutic targets for neuroprotection have emerged. We review the current understanding of neurodegenerative processes at play in MS and discuss potential outcome measures and targets for neuroprotection trials.
引用
收藏
页码：799 / 815
页数：16
相关论文
共 961 条
  • [51] Zeis T(2002)Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains Lancet Neurol 1 232-6120
  • [52] Graumann U(2000)The role of nitric oxide in multiple sclerosis Am J Pathol 157 267-530
  • [53] Reynolds R(2003)Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions J Neurol Neurosurg Psychiatry 74 695-53
  • [54] Schaeren-Wiemers N(2001)Axonal injury in multiple sclerosis J Virol 75 6115-382
  • [55] Shirani A(2003)Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus Brain 126 515-600
  • [56] Zhao Y(2008)Axonal damage: a key predictor of outcome in human CNS diseases J Neurol Sci 274 48-v15
  • [57] Karim ME(2011)Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity Neurosci Bull 27 366-299
  • [58] Evans C(2002)Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories Annu Rev Pharmacol Toxicol 42 585-35
  • [59] Kingwell E(2005)The biochemistry and physiology of S-nitrosothiols J Neurol 252 v10-291
  • [60] van der Kop ML(2006)Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis Acta Neuropathol 111 289-1252
12345678910